VAERS Explorer
Back to explore

Report #2827185

Received Mar 7, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
6 yrs
State
ND
Recovered
Unknown
Vaccinated
Jan 9, 2025
Onset
Jan 9, 2025
Days to onset
0
Hospital days
—

Vaccines (7)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNA13044210IM / RL
IPVPOLIO VIRUS, INACT. (IPOL)SANOFI PASTEUR2W1C831MSC / RL
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.2Y013583SC / LL
COVID19COVID19 (COVID19 (MODERNA))MODERNAUNK3044210OT
IPVPOLIO VIRUS, INACT. (IPOL)SANOFI PASTEURUNKW1C831MOT
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.UNK——
UNKVACCINE NOT SPECIFIED (NO BRAND NAME)UNKNOWN MANUFACTURER2Y013583OT / LL

Symptoms (2)

Product storage errorNo adverse event

Symptom narrative

No additional adverse event was reported; Improper storage of product in use; This spontaneous report was received from a nurse and refers to a 6-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 09-Jan-2025, the patient started therapy with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), (lot #Y013583, expiration date: 03-Feb-2026), dose number 2, administered by Subcutaneous route in Left Thigh for prophylaxis. On 09-Jan-2025, the patient started therapy with sterile diluent (MERCK STERILE DILUENT), for prophylaxis (lot # and expiration date were not reported). On 09-Jan-2025, the patient started therapy with Moderna COVID-19 vaccine (Elasomeran) (lot #3044210) (Dose 1, right thigh), administered by Intramuscular route for prophylaxis (expiration date was not reported). On 09-Jan-2025, the patient started therapy with Ipol (Polio vaccine inact 3v (Vero)) (lot #W1C831M) (Dose 2, right thigh), administered by Subcutaneous route for prophylaxis (expiration date was not reported). Those product were stored in inappropriate temperature (Product storage error). No additional adverse event was reported.; Sender's Comments: Priority : 5 , Is case serious : No , Index user : , Index date : 2025-02-26 , MNSC number : , CLIC number : , ESTAR number : , IRMS number : 11/14/2018 , Central date : 2025-02-20 , Classification : DMC, Attachment description : Post Marketing Basic , Safety case number :